MIT Biotechnology Group

MBG Seminar: Series Overview, Target ID & Validation, 9/27 4:30 pm

;color:rgb(0,0,0);font-size:14px”>

Hear from Amgen scientists about:
– identifying a possible therapeutic target and its role in disease
– increasing therapeutic efficacy and safety, process development, devices, and manufacturing
– case studies from bench to clinic
The series will conclude with a tour of the Amgen Massachusetts site

Future topics:
10/4   Large Molecule Lead Generation
10/11  Small Molecule Lead Generation
10/18  Comparative Biology and Safety Sciences
10/25  Pharmacokinetics and Drug Metabolism
11/1  Computational Chemistry
11/8  Process Development: Large/Small Molecule
11/15  Regulators and Clinical Trials
11/29  Case study (Neuroscience)
12/6  Case study (Bone Biology)
12/13  Amgen Massachusetts facility tour

Leave a Reply